Similarly, individuals with the GSTO1*AA genotype rs4925 had higher odds of diabetic nephropathy development compared to the carriers of the wild-type GSTO1*CC genotype, however with borderline significance (OR = 3.81, 95%CI = 0.85–17.09, p = 0.081). The gene discussed is GSTO1; the disease is diabetic kidney disease.